Quest Diagnostics Offers Agilent’s Resolution ctDx FIRST Liquid Biopsy Test
The liquid biopsy ctDx FIRST test is FDA approved as a companion diagnostic for advanced non-small cell lung cancer (NSCLC) patients.
Read More
Search Results for: lung cancer
Patent Issued for Early Detectable Blood-Based Biomarker for Alzheimer’s
A U.S. patent that focuses on the development of a novel blood-based biomarker for the early detection of Alzheimer’s has been issued.
Read More
Micronoma Gets Breakthrough Device Designation for Liquid Biopsy Assay that Detects Lung Carcinoma
Micronoma announced its OncobiotaLUNG assay received the Breakthrough Device Designation from the U.S. FDA for lung carcinoma detection.
Read More
Multi-omics Liquid Biopsy Platform Aids in Early-Stage Cancer Detection of NSCLC
PrognomiQ unveiled results from multi-omics study demonstrating the power of diverse molecular biomarkers in the early cancer detection.
Read More
Burning Rock’s Multi-Cancer Detection Blood Test Gets FDA Breakthrough Device Designation
Burning Rock announced that its OverC Multi-Cancer Detection Blood Test has been granted Breakthrough Device Designation by the FDA.
Read More